secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0000886163-24-000039
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ligand completes $75M purchase of Agenus royalty rights
-------------------------------------------------------

- Completed purchase of royalty rights from Agenus Inc. for $75M on May 29, 2024.
- Transaction previously announced on May 7, 2024; customary closing conditions satisfied.
- No other terms or financial impact disclosed beyond the purchase price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000088616324000039/0000886163-24-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000088616324000039/lgnd-20240529.htm
  HTML page:      https://secwatch.observer/filing/0000886163-24-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer